广汽(02238.HK):冀2025年新能源车销量占比20% 与腾讯战略合作将再升级
据《财联社》报道,广汽集团(02238.HK)宣布计划在2025年,实现全集团新能源汽车销量占比20%,混动化占比超20%;自主品牌全面实现电气化,新能源汽车占比超36%,强混占比超15%。
面向2035年,广汽集团力争全面实现电气化转型,实现汽车产销500万辆,其中节能汽车和新能源汽车各占50%。今年,广汽集团还计划投放10台氢燃料电池车,通过如祺出行,率先实现粤港澳大湾区首个「约车+FCV」示范运行。与腾讯(00700.HK)的战略合作也将再次升级,今天内完成签约。(wl/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.